Review article · 2023 · Open access

Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer

Rui Ni, Ziwei Li, Li Li, Dan Peng, Yue Ming, Lin Li, Yao Liu

Frontiers in Oncology, 13, 1143798 · Published 7 March 2023 · DOI 10.3389/fonc.2023.1143798

Open PDFView at the publisherCite this paper

In brief

“Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer” is a 2023 review article by Rui Ni and 6 co-authors, published in Frontiers in Oncology. OpenAlex counts 66 citations as of 22 November 2026, which puts it in the top 3% of works published in 2023 by citations. It is open access under a CC BY licence: the full text is free to read at Frontiers in Oncology.

Citations
66
Most cited in
2025 (26)
Field-weighted impact
1.60
References
254
Authors
7

Abstract

Glutamine, the most abundant non-essential amino acid in human blood, is crucial for cancer cell growth and cancer progression. Glutamine mainly functions as a carbon and nitrogen source for biosynthesis, energy metabolism, and redox homeostasis maintenance in cancer cells. Dysregulated glutamine metabolism is a notable metabolic characteristic of cancer cells. Some carcinogen-driven cancers exhibit a marked dependence on glutamine, also known as glutamine addiction, which has rendered the glutamine metabolic pathway a breakpoint in cancer therapeutics. However, some cancer cells can adapt to the glutamine unavailability by reprogramming metabolism, thus limiting the success of this therapeutic approach. Given the complexity of metabolic networks and the limited impact of inhibiting glutamine metabolism alone, the combination of glutamine metabolism inhibition and other therapeutic methods may outperform corresponding monotherapies in the treatment of cancers. This review summarizes the uptake, transport, and metabolic characteristics of glutamine, as well as the regulation of glutamine dependence by some important oncogenes in various cancers to emphasize the therapeutic potential of targeting glutamine metabolism. Furthermore, we discuss a glutamine metabolic pathway, the glutaminase II pathway, that has been substantially overlooked. Finally, we discuss the applicability of polytherapeutic strategies targeting glutamine metabolism to provide a new perspective on cancer therapeutics.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Ni, R., Li, Z., Li, L., Peng, D., Ming, Y., Li, L., & Liu, Y. (2023). Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer. Frontiers in Oncology, 13, 1143798. https://doi.org/10.3389/fonc.2023.1143798

MLA 9

Ni, Rui, et al. “Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer.” Frontiers in Oncology, vol. 13, 2023, p. 1143798. https://doi.org/10.3389/fonc.2023.1143798.

Chicago

Ni, Rui, Ziwei Li, Li Li, Dan Peng, Yue Ming, Lin Li, and Yao Liu. 2023. “Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer.” Frontiers in Oncology 13: 1143798. https://doi.org/10.3389/fonc.2023.1143798.

Harvard

Ni, R. et al. (2023) ‘Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer’, Frontiers in Oncology, 13, p. 1143798. doi:10.3389/fonc.2023.1143798.

IEEE

R. Ni et al., “Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer,” Frontiers in Oncology, vol. 13, p. 1143798, 2023, doi: 10.3389/fonc.2023.1143798.

BibTeX

@article{ni2023rethinking,
  title     = {{Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer}},
  author    = {Ni, Rui and Li, Ziwei and Li, Li and Peng, Dan and Ming, Yue and Li, Lin and Liu, Yao},
  journal   = {Frontiers in Oncology},
  year      = {2023},
  volume    = {13},
  pages     = {1143798},
  doi       = {10.3389/fonc.2023.1143798},
  url       = {https://doi.org/10.3389/fonc.2023.1143798}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202366
20241313
20252626
20262121

Its field-weighted citation impact is 1.60: it has been cited 1.60 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism

  • glutamine metabolism
  • glutamine addiction
  • oncogenes
  • cancer metabolism
  • metabolic reprogramming
  • combination therapy
  • cancer therapeutics
  • redox homeostasis

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Ni, R., Li, Z., Li, L., Peng, D., Ming, Y., Li, L., & Liu, Y. (2023). Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer. Frontiers in Oncology, 13, 1143798. https://doi.org/10.3389/fonc.2023.1143798

How many times has this paper been cited?

66 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Frontiers in Oncology: sign in and open the PDF from this page.

Who wrote this paper?

Rui Ni, Ziwei Li, Li Li, Dan Peng, Yue Ming, Lin Li, Yao Liu.

What is the DOI of this paper?

10.3389/fonc.2023.1143798, permanently at https://doi.org/10.3389/fonc.2023.1143798. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.